This HTML5 document contains 134 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
n10http://dx.doi.org/10.1158/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
schemahttp://schema.org/
skoshttp://www.w3.org/2004/02/skos/core#
rdfshttp://www.w3.org/2000/01/rdf-schema#
phttp://www.wikidata.org/prop/
wikibasehttp://wikiba.se/ontology#
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n12http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q38371186
rdf:type
wikibase:Item
schema:description
naučni članak tudományos cikk 2015年學術文章 artigo científico 2015年学术文章 научная статья artículu científicu espublizáu en 2015 מאמר מדעי مقالهٔ علمی artykuł naukowy artikull shkencor wetenschappelijk artikel bilimsel makale ২০১৫-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ vitskapeleg artikkel article científic научни чланак 2015年學術文章 artigo científico (publicado na 2015) 2015年學術文章 2015年学术文章 articolo scientifico article scientific videnskabelig artikel (udgivet 2015) επιστημονικό άρθρο tieteellinen artikkeli سائنسی مضمون 2015年學術文章 artikulong pang-agham 2015年學術文章 գիտական հոդված artículo científico publicado en 2015 2015年学术文章 2015年の論文 наукова стаття, опублікована в березні 2015 scienca artikolo mokslinis straipsnis мақолаи илмӣ scientific article научна статия wissenschaftlicher Artikel 2015년 논문 vetenskaplig artikel 2015 nî lūn-bûn 2015年學術文章 научни чланак vědecký článek บทความทางวิทยาศาสตร์ 2015年学术文章 articol științific teaduslik artikkel article scientifique (publié 2015) vedecký článok bài báo khoa học სამეცნიერო სტატია artigo científico (publicado na 2015) vitenskapelig artikkel мақолаи илмӣ 2015年学术文章 مقالة علمية نشرت بتاريخ 9-3-2015
p:P577
wds:Q38371186-0CF414CA-B5B4-42B7-96DD-B87FF25E51CC
wdt:P577
2015-03-09T00:00:00Z
p:P407
wds:Q38371186-CBBCB29E-B9E8-4129-8FD6-AD1F9E67F69B
wdt:P407
wd:Q1860
p:P2093
wds:Q38371186-EA3214E0-3384-4E36-8B6A-08B4B881E7DF wds:Q38371186-BD90C085-9D7F-4257-9672-4CA963118CBF wds:Q38371186-C022ACBF-7087-460C-8A7F-AF8A24D8987B wds:Q38371186-EA8B07DA-6152-43AA-8715-920B0B61855B wds:Q38371186-F86AE9AE-062B-47E1-B8F2-0FAF031A86EC wds:Q38371186-A75C0024-AA4A-48FC-BEBC-2B7A25AAEE86 wds:Q38371186-A79ED010-6E56-4FB9-B8AF-998BC1179348 wds:Q38371186-A0E4B39C-5DEC-4209-9B55-5D98CCFEBCC4 wds:Q38371186-A13E12E2-956F-44CB-853D-24E8CEE87661 wds:Q38371186-AF3F8A70-E454-4B6B-A1D2-EBF76431014C wds:Q38371186-ADF4D107-8101-43B7-8BC6-5FC4D47D5D71 wds:Q38371186-6B5129C7-4562-4CA6-A2E0-AA5F7446F40F wds:Q38371186-740BEA07-6EFB-4A39-A1AD-8CA875514223 wds:Q38371186-5DD6B362-3A17-49CA-B339-F5C1AA3D9484 wds:Q38371186-65EF22EB-4714-4915-ABFD-AE76851060C3 wds:Q38371186-8F0FCDBE-4B2B-41B3-9DEE-793CFA71E691 wds:Q38371186-8510117A-875E-4001-AF10-222604D05D0B wds:Q38371186-0E3F771D-49CE-459E-87B5-3C1EEA82DDB0 wds:Q38371186-41605CE2-60B2-4C7A-8C21-A0C1EA0585D5
wdt:P2093
Ruby Leong Yuzhuo Pan Ali Al Hakim Hong Zhao Emily Fox Pengfei Song Karen Boyd Margaret Brower Whitney Helms Donghao Lu Gideon M Blumenthal Richard Pazdur Patricia Keegan Qi Liu Ping Zhao Lijun Zhang Robert Justice Shenghui Tang Zhe Tang
rdfs:label
FDA approval: ceritinib for the treatment of metastatic anaplastic lymphoma kinase-positive non-small cell lung cancer. FDA approval: ceritinib for the treatment of metastatic anaplastic lymphoma kinase-positive non-small cell lung cancer. FDA approval: ceritinib for the treatment of metastatic anaplastic lymphoma kinase-positive non-small cell lung cancer.
skos:prefLabel
FDA approval: ceritinib for the treatment of metastatic anaplastic lymphoma kinase-positive non-small cell lung cancer. FDA approval: ceritinib for the treatment of metastatic anaplastic lymphoma kinase-positive non-small cell lung cancer. FDA approval: ceritinib for the treatment of metastatic anaplastic lymphoma kinase-positive non-small cell lung cancer.
schema:name
FDA approval: ceritinib for the treatment of metastatic anaplastic lymphoma kinase-positive non-small cell lung cancer. FDA approval: ceritinib for the treatment of metastatic anaplastic lymphoma kinase-positive non-small cell lung cancer. FDA approval: ceritinib for the treatment of metastatic anaplastic lymphoma kinase-positive non-small cell lung cancer.
p:P50
wds:Q38371186-AFEA4B5F-FB4F-48E8-A772-AF7DDFE15852
wdt:P50
wd:Q48504033
p:P1476
wds:Q38371186-2F10A4D8-14FF-4FA1-9468-20CC9509D644
wdt:P1476
FDA approval: ceritinib for the treatment of metastatic anaplastic lymphoma kinase-positive non-small cell lung cancer
p:P304
wds:Q38371186-1957851E-7E23-4300-998C-A27959AFC303
wdt:P304
2436-2439
p:P31
wds:Q38371186-1C10C597-FBC2-46BD-AEB8-C18785C36655
wdt:P31
wd:Q13442814
p:P921
wds:Q38371186-9DCE13F5-EDA7-47C7-96DF-9515E9ED62FC
wdt:P921
wd:Q21011233
p:P698
wds:Q38371186-874ED5E1-0C75-4DC9-BD05-C14E754B1BBC
wdtn:P698
n12:25754348
wdt:P698
25754348
p:P1433
wds:Q38371186-3A902507-CFD9-4CFA-A8ED-EDFB69E78D29
wdt:P1433
wd:Q332253
p:P433
wds:Q38371186-AE4CAD8E-DE9C-4BF4-B9B6-236544854FA7
p:P478
wds:Q38371186-464FE7BF-002B-4FA6-9715-4C49FE1CE66F
wdt:P433
11
wdt:P478
21
p:P356
wds:Q38371186-347465AF-FE77-4CD5-98B4-1BE12AF607A6
wdtn:P356
n10:1078-0432.CCR-14-3157
wdt:P356
10.1158/1078-0432.CCR-14-3157